Eye Hospital Pristina Kosovo
13
0
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Intrastromal Fresh Human Corneal Lenticule Implantation Using Smile Surgery for Treatment of Irregular Corneal Astigmatism After Penetrating Keratoplasty (new Approach)
Role: lead
Human Fresh Corneal Lenticule Implantation Criteria in Progressive Corneal Disease Using Relex-Smile
Role: lead
Treatment of Residual Hypermetropic Refraction on Pseudophakic Patients Using Allogenic Fresh Myopic Lenticule
Role: lead
Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
Role: lead
Treatment of Residual Refraction Errors 6 Months After Trifocal IOL Implantation With Relex-Smile
Role: lead
Fresh Corneal Lenticule Implantation and Autologous Serum - Case Report
Role: lead
Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism
Role: lead
Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile
Role: lead
Stromal Lenticule Implantation for Management of Herpetic Stromal Keratitis
Role: lead
A New Successful Approach for Emmetropic Presbyopic Patients Using Intrastromal Pocket With Smile Module
Role: lead
Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implantation With ReLEX Smile Surgery
Role: lead
Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex Smile Surgery
Role: lead
Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment
Role: lead
All 13 trials loaded